Statin prescriptions and breast cancer recurrence risk: a Danish nationwide prospective cohort study.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of the National Cancer Institute

• Publication date

  2011-10-05

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/jnci/djr291PMID 21813413PMCID PMC3186780
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials

  2011cited by this paper
• Use of antidepressants and NSAIDs in relation to mortality in long‐term breast cancer survivors

  2011cited by this paper
• Effect of obesity on prognosis after early-stage breast cancer.

  2011cited by this paper
• Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials

  2010cited by this paper
• Lipophilic Statin Use and Risk of Breast Cancer Subtypes

  2010cited by this paper
• Pravastatin use and cancer risk: a meta‐analysis of individual patient data from long‐term prospective controlled trials in Japan

  2010cited by this paper
• A most stubborn bias: no adjustment method fully resolves confounding by indication in observational studies.

  2010cited by this paper
• Statin Use and Risk of Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders

  2010cited by this paper
• Aspirin intake and survival after breast cancer.

  2010cited by this paper
• Fluvastatin reduces proliferation and increases apoptosis in women with high grade breast cancer

  2009cited by this paper
• Post-diagnosis statin use and breast cancer recurrence in a prospective cohort study of early stage breast cancer survivors

  2008cited by this paper
• Screening statins for possible carcinogenic risk: up to 9 years of follow‐up of 361 859 recipients

  2008cited by this paper
• Statin use and prostate cancer risk in a large population-based setting

  2008cited by this paper
• Renin‐angiotensin system inhibitors, angiotensin I‐converting enzyme gene insertion/deletion polymorphism, and cancer

  2008cited by this paper
• Use of Common Medications and Breast Cancer Risk

  2008cited by this paper
• Danish Breast Cancer Cooperative Group – DBCG: History, organization, and status of scientific achievements at 30-year anniversary

  2008cited by this paper
• Post-diagnosis statin use and breast recurrence sites in early stage breast cancer survivors

  2008cited by this paper
• Trends in Statin Use and Low-Density Lipoprotein Cholesterol Levels Among US Adults: Impact of the 2001 National Cholesterol Education Program Guidelines

  2008influential reference
• Statins and cancer: A systematic review and meta-analysis.

  2008cited by this paper
• Pleiotropic effects of statin therapy: molecular mechanisms and clinical results.

  2008cited by this paper
• Update on statins

  2008cited by this paper
• Statins and cancer: a meta-analysis of case–control studies

  2008cited by this paper
• Prediagnostic Use of Hormone Therapy and Mortality After Breast Cancer

  2008cited by this paper
• Estrogen Receptor–Negative Breast Cancer Is Less Likely to Arise among Lipophilic Statin Users

  2008cited by this paper
• The clinical database and the treatment guidelines of the Danish Breast Cancer Cooperative Group (DBCG); its 30-years experience and future promise

  2008cited by this paper
• NSAIDs and breast cancer recurrence in a prospective cohort study

  2007cited by this paper
• Statins and risk of cancer: A systematic review and metaanalysis

  2007cited by this paper
• A call for clinical trials: lipophilic statins may prove effective in treatment and prevention of particular breast cancer subtypes.

  2006cited by this paper
• Statin use and breast cancer: prospective results from the Women's Health Initiative.

  2006cited by this paper
• Statins and the Risk of Lung, Breast, and Colorectal Cancer in the Elderly

  2006cited by this paper
• Breast cancer growth prevention by statins.

  2006cited by this paper
• Association of statin use with improved local control in patients treated with selective bladder preservation for muscle-invasive bladder cancer.

  2006cited by this paper
• Statins and cancer risk: a meta-analysis.

  2006cited by this paper
• Easy SAS calculations for risk or prevalence ratios and differences.

  2005cited by this paper
• Pleiotropic effects of statins.

  2005cited by this paper
• Cancer risk among statin users: A population‐based cohort study

  2005cited by this paper
• Use of statins and breast cancer: a meta-analysis of seven randomized clinical trials and nine observational studies.

  2005cited by this paper
• Association of statin use with a pathologic complete response to neoadjuvant chemoradiation for rectal cancer.

  2005cited by this paper
• Therapy Insight: potential of statins for cancer chemoprevention and therapy

  2005cited by this paper
• Serum lipids, lipid-lowering drugs, and the risk of breast cancer.

  2005cited by this paper
• The association between 3‐hydroxy‐3‐methylglutaryl conenzyme A inhibitor use and breast carcinoma risk among postmenopausal women

  2004cited by this paper
• Update on Statins: 2003

  2004cited by this paper
• Apoptotic injury in cultured human hepatocytes induced by HMG-CoA reductase inhibitors.

  2004cited by this paper
• Update on statins.

  2004cited by this paper
• Hypercholesterolemia impairs angiogenesis in patients with breast carcinoma and, therefore, lowers the risk of metastases.

  2004cited by this paper
• Time trends and regional differences in registration, stage distribution, surgical management and survival of breast cancer in Denmark.

  2003cited by this paper
• Incidence of cancer after prophylaxis with warfarin against recurrent venous thromboembolism. Duration of Anticoagulation Trial.

  2000cited by this paper
• Pleiotropic effects of statins

  2000cited by this paper
• Hydrophilicity/lipophilicity: relevance for the pharmacology and clinical effects of HMG-CoA reductase inhibitors.

  1998cited by this paper
• Quality control of end results in a Danish adjuvant breast cancer multi-center study.

  1997cited by this paper
• Survival analysis using the SAS system : a practical guide

  1995cited by this paper
• A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

  1987cited by this paper
• Multivalent feedback regulation of HMG CoA reductase, a control mechanism coordinating isoprenoid synthesis and cell growth.

  1980cited by this paper
• Hepatocellular Carcinoma (hcc) Causes Death in Patients with Cirrhosis and Is One of the Most Prevalent Malignant Tumours Effect of Pravastatin on Survival in Patients with Advanced Hepatocellular Carcinoma. a Randomized Controlled Trial

  year unknowncited by this paper

• Antitumoral and cardioprotective roles of statins: underlying types, mechanisms, current evidence, and emerging perspectives.

  2026cites this paper
• Stress-Inducible Transcription Factor NUPR1 Is Involved in the Inhibitory Effects Exerted by Statins on Insulin Action in ER-Positive Breast Cancer Cells

  2026cites this paper
• Cholesterol efflux protein, ABCA1, supports anticancer functions of myeloid immune cells

  2026cites this paper
• Association between low-dose aspirin use and breast cancer recurrence: a Danish nationwide cohort study with up to 23 years of follow-up

  2025cites this paper
• Cholesterol desensitizes the response of endometrial cancer to progestin by attenuating progestin signaling.

  2025cites this paper
• Causal analyses of the impact of comorbid conditions and concomitant medications on response to neoadjuvant chemotherapy in breast cancer: analysis of a multicenter prospective cohort study (CANTO)

  2025cites this paper
• Targeting Ferroptosis as the Achilles’ Heel of Breast Cancer: Mechanisms and Therapeutic Opportunities from a Comprehensive Systematic Review

  2025cites this paper
• Drug Interactions With Tamoxifen and Treatment Effectiveness in Premenopausal Breast Cancer Patients: A Bayesian Joint Modeling Approach

  2025cites this paper
• Statins in the context of precision cancer medicine: important factors to consider

  2025cites this paper
• The Contribution of Cholesterol and Squalene Synthase in Cancer: Molecular Mechanisms, Lipid Rafts and Therapeutic Approaches

  2025cites this paper
• Statins as Secondary Preventive Agent to Limit Breast Cancer Metastatic Outgrowth

  2025cites this paper
• The role of statins in breast cancer survivors

  2025cites this paper
• Statins and prognosis of female breast cancer: a meta-analysis

  2025cites this paper
• Cholesterol efflux protein, ABCA1, supports anti-cancer functions of myeloid immune cells

  2025cites this paper
• Statin use and breast cancer-specific mortality and recurrence: a systematic review and meta-analysis including the role of immortal time bias and tumour characteristics

  2025cites this paper
• Lipid-laden macrophages in atherosclerosis and cancer.

  2025cites this paper
• Association of statin use on survival outcomes of patients with early-stage HER2-positive breast cancer in the APHINITY trial

  2025cites this paper
• HMGCR: a malignancy hub - frontiers in cancer diagnosis and therapy

  2025cites this paper
• Risk Factors and Prevention of Cancer and CVDs: A Chicken and Egg Situation

  2025cites this paper
• Lipid metabolic reprograming: the unsung hero in breast cancer progression and tumor microenvironment

  2025cites this paper
• Neutrophils exposed to a cholesterol metabolite secrete extracellular vesicles that promote epithelial-mesenchymal transition and stemness in breast cancer cells.

  2025cites this paper
• Postdiagnosis Statin Use and Breast Cancer Mortality

  2025cites this paper
• Beyond cardiovascular health: The pharmacotherapeutic potential of statins in oncology.

  2025cites this paper
• Clinical significance of lipid pathway-targeted therapy in breast cancer

  2025cites this paper
• Statin Therapy in Early Breast Cancer: The MASTER Trial; A Randomized Phase III, Placebo-Controlled Comparison of Standard (Neo)Adjuvant Therapy Plus Atorvastatin versus Standard (Neo)Adjuvant Therapy Plus Placebo

  2025cites this paper
• Cross-pollination of two specialties: potential repurposing of cancer and cardiovascular drugs for the benefit of the other.

  2025cites this paper
• Statins Are Not Associated with Improved Bladder Cancer Outcomes in Patients with Early-Stage Bladder Cancer Treated with BCG Immunotherapy

  2025cites this paper
• Mediation effects of metabolites and sex hormones on the relationship between body mass index and breast cancer: Mendelian randomization analysis and mediation analysis

  2024cites this paper
• The Effect of Statins on Markers of Breast Cancer Proliferation and Apoptosis in Women with In Situ or Early-Stage Invasive Breast Cancer

  2024cites this paper
• Role of low‐density cholesterol and Interleukin‐17 interaction in breast cancer pathogenesis and treatment

  2024cites this paper
• Why make it if you can take it: review on extracellular cholesterol uptake and its importance in breast and ovarian cancers

  2024cites this paper
• Impact of statin use in head and neck cancer: a nested case–control study

  2024cites this paper
• Post-surgery statin use contributes to favorable outcomes in patients with early breast cancer.

  2024cites this paper
• Unveiling the association between HMG-CoA reductase inhibitors and bladder cancer: a comprehensive analysis using Mendelian randomization, animal models, and transcriptomics

  2024cites this paper
• Protein lipidation in health and disease: molecular basis, physiological function and pathological implication

  2024cites this paper
• Ezetimibe inhibits the migration and invasion of triple‐negative breast cancer cells by targeting TGFβ2 and EMT

  2024cites this paper
• Characterization of dipyridamole as a novel ferroptosis inhibitor and its therapeutic potential in acute respiratory distress syndrome management

  2024cites this paper
• Dysregulated Ribosome Biogenesis Is a Targetable Vulnerability in Triple-Negative Breast Cancer: MRPS27 as a Key Mediator of the Stemness-inhibitory Effect of Lovastatin

  2024cites this paper
• Statin therapy: a potential adjuvant to immunotherapies in hepatocellular carcinoma

  2024cites this paper
• Are statins onco- suppressive agents for every type of tumor? A systematic review of literature

  2024cites this paper
• Cancer and Cardiovascular Disease: The Conjoined Twins

  2024cites this paper
• Statin use and risks of breast cancer recurrence and mortality

  2024cites this paper
• PLGA and PDMS-based in situ forming implants loaded with rosuvastatin and copper-selenium nanoparticles: a promising dual-effect formulation with augmented antimicrobial and cytotoxic activity in breast cancer cells

  2024cites this paper
• Concomitant medication, comorbidity and survival in patients with breast cancer

  2024cites this paper
• Statin use is associated with a lower risk of all-cause death in patients with breast cancer treated with anthracycline containing regimens: a global federated health database analysis

  2024cites this paper
• Lipid-lowering drugs and cancer: an updated perspective

  2023cites this paper
• Fluvastatin prevents lung metastasis in triple-negative breast cancer by triggering autophagy via the RhoB/PI3K/mTOR pathway.

  2023cites this paper
• Functional significance of cholesterol metabolism in cancer: from threat to treatment

  2023cites this paper
• Cancer Metabolism as a Therapeutic Target and Review of Interventions

  2023cites this paper
• Low-dose aspirin, statins, and metformin and survival in patients with breast cancers: a Norwegian population-based cohort study

  2023cites this paper
• Impact of statin use on breast cancer recurrence and mortality before and after diagnosis: a systematic review and meta-analysis

  2023cites this paper
• DAXX drives de novo lipogenesis and contributes to tumorigenesis

  2023cites this paper
• Enhancing the anticancer immune response with the assistance of drug repurposing and delivery systems

  2023cites this paper
• Impact of oral statin therapy on clinical outcomes in patients with cT1 breast cancer

  2023cites this paper
• The role of HMGCR expression in combination therapy of simvastatin and FAC treated locally advanced breast cancer patients

  2023cites this paper
• Post-diagnostic statin use and breast cancer-specific mortality: a population-based cohort study

  2023cites this paper
• New insights into the therapeutic potentials of statins in cancer

  2023cites this paper
• Statins as a Secondary Preventive Agent for Metastatic Cancer.

  2023cites this paper
• Post-Diagnostic Statin Use and its Association with Cancer Recurrence and Mortality in Breast Cancer Patients: A Systematic Review and Meta-analysis.

  2023cites this paper
• p140Cap modulates the mevalonate pathway decreasing cell migration and enhancing drug sensitivity in breast cancer cells

  2023cites this paper
• HMG-CoA reductase degrader, SR-12813, counteracts statin-induced upregulation of HMG-CoA reductase and augments the anticancer effect of atorvastatin.

  2023cites this paper
• Cholesterol de novo biosynthesis: a promising target to overcome the resistance to aromatase inhibitors in postmenopausal patients with estrogen receptor-positive breast cancer

  2023cites this paper
• Statin use and patterns of breast cancer recurrence in the Malmö Diet and Cancer Study

  2022cites this paper
• Statins and renal cell carcinoma: antitumor activity and influence on cancer risk and survival.

  2022cites this paper
• Tamoxifen: The Past, Present, and Future of a Previous Orphan Drug

  2022cites this paper
• Computational pharmacogenomic screen identi es drugs that phenocopy dipyridamole and potentiate anti-breast cancer activity of statins

  2022cites this paper
• Use of Hypolipidemic Drugs and the Risk of Second Primary Malignancy in Colorectal Cancer Patients

  2022cites this paper
• Mutant p53, the Mevalonate Pathway and the Tumor Microenvironment Regulate Tumor Response to Statin Therapy

  2022cites this paper
• Formulation of simvastatin within high density lipoprotein enables potent tumour radiosensitisation.

  2022cites this paper
• Ultrasound assisted one-pot synthesis of rosuvastatin based novel azaindole derivatives via coupling-cyclization strategy under Pd/Cu-catalysis: Their evaluation as potential cytotoxic agents.

  2022cites this paper
• Effect of concomitant statin treatment in postmenopausal patients with hormone receptor-positive early-stage breast cancer receiving adjuvant denosumab or placebo: a post hoc analysis of ABCSG-18

  2022cites this paper
• Relationship between serum lipid levels and the immune microenvironment in breast cancer patients: a retrospective study

  2022cites this paper
• Lipidomic and Membrane Mechanical Signatures in Triple-Negative Breast Cancer: Scope for Membrane-Based Theranostics

  2022cites this paper
• Statins for Cardiac and Vascular Protection During and After Cancer Therapy

  2022cites this paper
• Polyploid giant cancer cells are dependent on cholesterol for progeny formation through amitotic division

  2022cites this paper
• The Link Between Statins and Breast Cancer in Mouse Models: A Systematic Review

  2022cites this paper
• Metabolic switch in cancer - Survival of the fittest.

  2022cites this paper
• [STE029 Overcomes EGFR-TKI Resistance in Human Lung Adenocarcinoma].

  2022cites this paper
• Computational pharmacogenomic screen identifies drugs that potentiate the anti-breast cancer activity of statins

  2022cites this paper
• Cholesterol: An important actor on the cancer immune scene

  2022cites this paper
• Statin use improves the prognosis of ovarian cancer: An updated and comprehensive meta-analysis

  2022cites this paper
• Interactive exploration of a global clinical network from a large breast cancer cohort

  2022cites this paper
• MicroRNA-dependent inhibition of WEE1 controls cancer stem-like characteristics and malignant behavior in ovarian cancer

  2022cites this paper
• Identification of crucial hub genes and potential molecular mechanisms in breast cancer by integrated bioinformatics analysis and experimental validation

  2022cites this paper
• Statin use in patients with hormone receptor‐positive metastatic breast cancer treated with everolimus and exemestane

  2022cites this paper
• The mevalonate pathway in breast cancer biology.

  2022cites this paper
• Organ-specific cholesterol metabolic aberration fuels liver metastasis of colorectal cancer

  2021cites this paper
• Simvastatin Is Effective in Killing the Radioresistant Breast Carcinoma Cells

  2021cites this paper
• Targeting obesity-related dysfunction in hormonally driven cancers

  2021cites this paper
• Association of antidiabetic medication and statins with survival from ductal and lobular breast carcinoma in women with type 2 diabetes

  2021cites this paper
• The relationship between post-diagnostic statin usage and breast cancer prognosis varies by hormone receptor phenotype: a systemic review and meta-analysis

  2021influential citation
• The Mevalonate Pathway, a Metabolic Target in Cancer Therapy

  2021cites this paper
• Simvastatin suppresses renal cell carcinoma cells by regulating DDX5/DUSP5

  2021cites this paper
• Cytotoxic and Pro-Apoptotic Effects of a Sub-Toxic Concentration of Fluvastatin on OVCAR3 Ovarian Cancer Cells After its Optimized Formulation to Melittin Nano-Conjugates

  2021cites this paper
• Mevalonate Pathway Inhibition Slows Breast Cancer Metastasis via Reduced N-glycosylation Abundance and Branching

  2021cites this paper
• Statins and endocrine resistance in breast cancer

  2021cites this paper
• How cancer cells remodel lipid metabolism: strategies targeting transcription factors

  2021cites this paper
• Letter to the editor regarding: "The relationship between post-diagnostic statin usage and breast cancer prognosis varies by hormone receptor phenotype: a systemic review and meta-analysis"

  2021cites this paper
• Preventing metastatic emergence of breast cancer

  2021cites this paper
• Statin use and incidence and mortality of breast and gynecology cancer: A cohort study using the National Health Insurance claims database

  2021cites this paper